TBEC, among dozens of civil society organizations and activists, calls for Cepheid to take the urgent steps necessary to ensure affordable, fair, and expanded access to GeneXpert testing at campaign support 1/4/6×24.
In an open letter, the organizations call Cepheid to play a leading role in diagnostic test companies by supporting the 1/4/6×24 Campaign and taking a number of obligations.
Recall that the essence of the 1/4/6x24 Campaign is that by the end of 2024 the countries pharmaceutical and diagnostic companies will have taken all necessary measures to improving access to the shortest treatment regimens recommended by WHO: one month or a week for tuberculosis prevention, four months for drug-susceptible TB, and six months for drug-resistant TB.
